Skip to main content

IB Acquisition Corp.

IBACR
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001998781

No open-market purchases or sales by IB Acquisition Corp. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $660.9K in total; no superinvestor holds it.

Other share classesIBAC

Holders of 5% or more of IBACR

Holders whose latest Schedule 13D or 13G filing reports 5% or more of IB Acquisition Corp., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of IBACR
HolderLatest formStakeChangeFirst filedLatest filingFiling
Meteora Capital, LLC13G5.14%543.3K sharesNewFeb 14, 20251 filingFeb 14, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

3 Schedule 13D and 13G filings on IB Acquisition Corp., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on IBACR
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 14, 202511:10 AM ETTD Securities (USA) LLCand 3 others13G/A0.00%0 shares−5.10 ppfrom 5.10%Below 5%Sep 30, 2025SEC
Aug 12, 20252:07 PM ETTD Securities (USA) LLCand 3 others13G5.10%806.4K sharesNewJun 30, 2025SEC
Feb 14, 202510:51 AM ETMeteora Capital, LLCand 1 other13G5.14%543.3K sharesNewDec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell IB Acquisition Corp. shares.

No Form 144 notices for IB Acquisition Corp. are on file.